Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Neurol ; 14: 1100931, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36937509

RESUMO

We report a 63-year-old female patient with progressive supranuclear palsy (PSP). She presented predominant postural instability and "saccadic ping-pong gaze" (SPPG). She had unprovoked falls recurrently within a year from the onset of gait disturbance. She tended to fall backward with eye closure but had no freezing of gait on examination. She showed no signs of nuchal dystonia, limb tremor, rigidity, spasticity, or ataxia. The dopaminergic response was negative. On the initial examination, her vertical eye movements were normal, but frequent macro square wave jerks and SPPG were observed. SPPG consisted of short-cycle, horizontal conjugate irregular pendular oscillations of the eye position from the midpoint with superimposed small saccades. SPPG was observed usually in the dark, not in the daylight, and with eye closure by using electrooculogram and infrared charge-coupled device imaging. One and a half years after the first examination, she was diagnosed as probable PSP with vertical supranuclear gaze palsy. SPPG was first described in patients who are unconscious by Johkura in 1998 as a "saccadic" variant of "ping-pong gaze (PPG)." PPG, short-cycle periodic alternating gaze, has been described in comatose patients since 1967. On the other hand, abnormal eye movement, which looks the same as SPPG in coma, has been described in conscious patients with PSP or spinocerebellar degeneration (SCD) in Japanese literature since 1975. However, it has been called "transient alternating saccades (TAS)." Nowadays, we believe it is more appropriate to call this abnormal eye movement "SPPG" instead of TAS. Here, we propose that PSP, a neuro-degenerative disease, should be added as one of the etiologies of SPPG. We discuss the differences between PPG/SPPG in coma and SPPG in PSP and the possible pathophysiological mechanism of SPPG in relation to cerebellar oculomotor dysfunctions.

2.
Parasit Vectors ; 9: 134, 2016 Mar 09.
Artigo em Inglês | MEDLINE | ID: mdl-26956033

RESUMO

BACKGROUND: Toxoplasma gondii is a highly prevalent protozoan that can infect all warm-blooded animals, including humans. Its definitive hosts are Felidae and its intermediate hosts include various other mammals and birds, including pigs. It is found in the meat of livestock which is a major source of human infection. Hence the control of toxoplasmosis in pigs is important for public health. We previously showed that dextran sulfate (DS), especially DS10 (dextran sulfate MW 10 kDa), is effective against T. gondii infection both in vitro and in mice. In this study, we asked whether DS affects T. gondii infection of pigs, one of the main animal sources of toxoplasmosis transmission to humans. METHODS: Fourteen-day-old male pigs (n = 10) were infected with T. gondii and then immediately treated with different doses of DS10; clinical, pathological, and immunological analyses were performed 5 days post-infection. RESULTS: DS10 had an inhibitory effect on toxoplasmosis in pigs. Intravenous injection of DS10 prevented the symptoms of toxoplasmosis and reduced the parasite burden and inflammation induced by T. gondii infection. High-dose DS10 (500 µg per head) caused reversible hepatocellular degeneration of the liver; middle-dose DS10 (50 µg per head) was effective against toxoplasmosis in pigs without causing this side effect. CONCLUSIONS: Our data suggest that middle-dose DS10 led to minimal clinical symptoms of T. gondii infection and caused little hepatocellular degeneration in our pig model, thereby demonstrating its potential as a new treatment for toxoplasmosis. These data should be very beneficial to those interested in the control of toxoplasmosis in pigs.


Assuntos
Antiprotozoários/administração & dosagem , Sulfato de Dextrana/administração & dosagem , Toxoplasma/efeitos dos fármacos , Toxoplasmose/tratamento farmacológico , Administração Intravenosa , Animais , Antiprotozoários/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/patologia , Sulfato de Dextrana/efeitos adversos , Modelos Animais de Doenças , Suínos , Toxoplasmose/imunologia , Toxoplasmose/patologia
3.
Sci Rep ; 5: 11599, 2015 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-26129968

RESUMO

Cryptosporidium parvum is an apicomplexan parasite that can cause serious watery diarrhea, cryptosporidiosis, in human and other mammals. C. parvum invades gastrointestinal epithelial cells, which have abundant glycosaminoglycans on their cell surface. However, little is known about the interaction between C. parvum and glycosaminoglycans. In this study, we assessed the inhibitory effect of sulfated polysaccharides on C. parvum invasion of host cells and identified the parasite ligands that interact with sulfated polysaccharides. Among five sulfated polysaccharides tested, heparin had the highest, dose-dependent inhibitory effect on parasite invasion. Heparan sulfate-deficient cells were less susceptible to C. parvum infection. We further identified 31 parasite proteins that potentially interact with heparin. Of these, we confirmed that C. parvum elongation factor 1α (CpEF1α), which plays a role in C. parvum invasion, binds to heparin and to the surface of HCT-8 cells. Our results further our understanding of the molecular basis of C. parvum infection and will facilitate the development of anti-cryptosporidial agents.


Assuntos
Cryptosporidium parvum/patogenicidade , Heparina/farmacologia , Fator 1 de Elongação de Peptídeos/metabolismo , Polissacarídeos/farmacologia , Sulfatos/farmacologia , Animais , Células CHO , Linhagem Celular Tumoral , Chlorocebus aethiops , Cromatografia Líquida , Cricetulus , Cryptosporidium parvum/efeitos dos fármacos , Eletroforese em Gel de Poliacrilamida , Interações Hospedeiro-Parasita/efeitos dos fármacos , Immunoblotting , Ligantes , Camundongos Nus , Proteínas Recombinantes/metabolismo , Coloração pela Prata , Esporozoítos/efeitos dos fármacos , Esporozoítos/fisiologia , Espectrometria de Massas em Tandem
4.
Malar J ; 13: 487, 2014 Dec 11.
Artigo em Inglês | MEDLINE | ID: mdl-25495520

RESUMO

BACKGROUND: There is an urgent need to develop and test novel compounds against malaria infection. Carrageenans, sulphated polysaccharides derived from seaweeds, have been previously shown to inhibit Plasmodium falciparum in vitro. However, they are inflammatory and alter the permeability of the blood-brain barrier, raising concerns that their use as a treatment for malaria could lead to cerebral malaria (CM), a severe complication of the disease. In this work, the authors look into the effects of the administration of λ-carrageenan to the development and severity of CM in BALB/c mice, a relatively non-susceptible model, during infection with the ANKA strain of Plasmodium berghei. METHODS: Five-week-old female BALB/c mice were infected with P. berghei intraperitoneally. One group was treated with λ-carrageenan (PbCGN) following the 4-day suppressive test protocol, whereas the other group was not treated (PbN). Another group of healthy BALB/c mice was similarly given λ-carrageenan (CGN) for comparison. The following parameters were assessed: parasitaemia, clinical signs of CM, and mortality. Brain and other vital organs were collected and examined for gross and histopathological lesions. Evans blue dye assays were employed to assess blood-brain barrier integrity. RESULTS: Plasmodium berghei ANKA-infected BALB/c mice treated with λ-carrageenan died earlier than those that received no treatment. Histopathological examination revealed that intracerebral haemorrhages related to CM were present in both groups of infected BALB/c mice, but were more numerous in those treated with λ-carrageenan than in mock-treated animals. Inflammatory lesions were also observed only in the λ-carrageenan-treated mice. These observations are consistent with the clinical signs associated with CM, such as head tilt, convulsions, and coma, which were observed only in this group, and may account for the earlier death of the mice. CONCLUSION: The results of this study indicate that the administration of λ-carrageenan exacerbates the severe brain lesions and clinical signs associated with CM in BALB/c mice infected with P. berghei ANKA.


Assuntos
Antimaláricos/efeitos adversos , Carragenina/efeitos adversos , Fatores Imunológicos/efeitos adversos , Malária Cerebral/tratamento farmacológico , Malária Cerebral/patologia , Plasmodium berghei/efeitos dos fármacos , Animais , Antimaláricos/administração & dosagem , Carragenina/administração & dosagem , Modelos Animais de Doenças , Feminino , Fatores Imunológicos/administração & dosagem , Malária Cerebral/parasitologia , Camundongos Endogâmicos BALB C , Parasitemia/diagnóstico , Análise de Sobrevida
5.
Jpn J Vet Res ; 62(1-2): 17-24, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24979990

RESUMO

The 23-kDa piroplasm membrane protein of Theileria orientalis (p23) is an immunogenic protein expressed during the intraerythrocytic stage of the parasite; its function, however, remains unclear. To evaluate the host factor or factors that interact with p23, we examined the binding of p23 to components of the host cell surface. Recombinant p23 protein of the Ikeda genotype failed to bind to bovine red blood cells or to peripheral blood mononuclear cells, but did bind to Madin-Darby Bovine Kidney (MDBK) cells. A glycoarray assay showed that recombinant p23 proteins from the three genotypes bound to heparin, indicating that p23 is a heparin-binding Theileria surface molecule. Further analysis of heparin-binding molecules is useful for understanding attachment and invasion of T. orientalis merozoites.


Assuntos
Heparina/química , Proteínas de Membrana/metabolismo , Theileria/metabolismo , Animais , Linhagem Celular , Cães , Genótipo , Proteínas de Membrana/química , Oligossacarídeos/química , Oligossacarídeos/metabolismo , Análise Serial de Proteínas/métodos , Ligação Proteica , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo
6.
Sci Rep ; 4: 4723, 2014 Apr 17.
Artigo em Inglês | MEDLINE | ID: mdl-24740150

RESUMO

Here, we assessed the sulfated derivative of the microbial polysaccharide gellan gum and derivatives of λ and κ-carrageenans for their ability to inhibit Plasmodium falciparum 3D7 and Dd2 growth and invasion of red blood cells in vitro. Growth inhibition was assessed by means of flow cytometry after a 96-h exposure to the inhibitors and invasion inhibition was assessed by counting ring parasites after a 20-h exposure to them. Gellan sulfate strongly inhibited invasion and modestly inhibited growth for both P. falciparum 3D7 and Dd2; both inhibitory effects exceeded those achieved with native gellan gum. The hydrolyzed λ-carrageenan and oversulfated κ-carrageenan were less inhibitory than their native forms. In vitro cytotoxicity and anticoagulation assays performed to determine the suitability of the modified polysaccharides for in vivo studies showed that our synthesized gellan sulfate had low cytotoxicity and anticoagulant activity.


Assuntos
Malária Falciparum/tratamento farmacológico , Plasmodium falciparum/efeitos dos fármacos , Polissacarídeos/farmacologia , Ésteres do Ácido Sulfúrico/farmacologia , Animais , Eritrócitos/parasitologia , Citometria de Fluxo , Humanos , Técnicas In Vitro , Malária Falciparum/sangue , Malária Falciparum/parasitologia , Plasmodium falciparum/efeitos da radiação , Polissacarídeos/sangue , Ésteres do Ácido Sulfúrico/sangue
7.
Sci Rep ; 3: 3199, 2013 Nov 12.
Artigo em Inglês | MEDLINE | ID: mdl-24217438

RESUMO

Toxoplasma rhoptry neck protein 4 (TgRON4) is a component of the moving junction macromolecular complex that plays a central role during invasion. TgRON4 is exposed on the cytosolic side of the host cell during invasion, but its molecular interactions remain unclear. Here, we identified host cellular ß-tubulin as a binding partner of TgRON4, but not Plasmodium RON4. Coimmunoprecipitation studies in mammalian cells demonstrated that the C-terminal 15-kDa region of ß-tubulin was sufficient for binding to TgRON4, and that a 17-kDa region in the proximal C-terminus of TgRON4 was required for binding to the C-terminal region of ß-tubulin. Analysis of T. gondii-infected lysates from CHO cells expressing the TgRON4-binding region showed that the C-terminal region of ß-tubulin interacted with TgRON4 at early invasion step. Our results provide evidence for a parasite-specific interaction between TgRON4 and the host cell cytoskeleton in parasite-infected cells.


Assuntos
Interações Hospedeiro-Parasita/fisiologia , Peptídeo Hidrolases/metabolismo , Proteínas de Protozoários/metabolismo , Toxoplasma/metabolismo , Tubulina (Proteína)/metabolismo , Animais , Antígenos de Protozoários , Células CHO , Proteínas de Transporte/metabolismo , Células Cultivadas , Cricetinae , Cricetulus , Imunoprecipitação , Proteínas de Membrana/metabolismo , Plasmodium falciparum/metabolismo
8.
Parasitol Res ; 112(12): 4169-76, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24096605

RESUMO

Toxoplasma gondii is one of the most prevalent parasites, causing toxoplasmosis in various warm-blooded animals, including humans. Because of the broad range of hosts susceptible to T. gondii, it had been postulated that a universal component of the host cell surface, such as glycosaminoglycans (GAGs), may act as a receptor for T. gondii infection. Carruthers et al. (Infect Immun 68:4005-4011, 2000) showed that soluble GAGs have also been shown to disrupt parasite binding to human fibroblasts. Therefore, we investigated the inhibitory effect of GAGs and their analogue dextran sulfate (DS) on T. gondii infection. For up to 24 h of incubation after inoculation of T. gondii, the inhibitory effect of GAGs on T. gondii infection and growth inside the host cell was weak. In contrast, DS markedly inhibited T. gondii infection. Moreover, low molecular weight DS particularly slowed the growth of T. gondii inside host cells. DS10 (dextran sulfate MW 10 kDa) was the most effective agent in these in vitro experiments and was therefore tested for its inhibitory effects in animal experiments; infection inhibition by DS10 was confirmed under these in vivo conditions. In this report, we showed that DSs, especially DS10, have the potential of a new type of drug for toxoplasmosis.


Assuntos
Sulfato de Dextrana/farmacologia , Glicosaminoglicanos/farmacologia , Toxoplasma/efeitos dos fármacos , Animais , Chlorocebus aethiops , Feminino , Camundongos Endogâmicos BALB C , Toxoplasma/crescimento & desenvolvimento , Toxoplasmose/tratamento farmacológico , Toxoplasmose/parasitologia , Células Vero
9.
J Vet Med Sci ; 75(7): 837-40, 2013 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-23411407

RESUMO

Cattle are major hosts of Cryptosporidium. Cryptosporidiosis in neonatal calves is associated with retarded growth, weight loss and calf mortality, and zoonotic infections in humans. Fecal samples were collected from calves in Ishikari District, Hokkaido, Japan and examined by PCR and sequence analyses. Among the 107 fecal samples collected in May and June 2012, 25 (23%) were positive for Cryptosporidium, including 8 samples (7%) having C. parvum, 10 (9%) having C. bovis and 7 (7%) having C. ryanae. This is first time C. ryanae has been detected in Hokkaido. Furthermore, it is the first detection of C. ryanae from pre-weaned calves in Japan. Microscopic observation with the flotation method is powerful and traditional tool for screening for Cryptosporidium species, but it sometimes leads to low detection of Cryptosporidium with low oocyst shedding intensity. If calves with or without diarrhea are examined using the molecular diagnostic tools, C. bovis and C. ryanae might be detected in other areas of Japan including Hokkaido. Here, the zoonotic species, C. parvum, was also observed. Therefore, calves can be potential sources of cryptosporidial infections for humans and other animals. The detection of C. parvum was statistically correlated with diarrhea in calves.


Assuntos
Doenças dos Bovinos/epidemiologia , Doenças dos Bovinos/parasitologia , Criptosporidiose/veterinária , Cryptosporidium/genética , Diarreia/veterinária , Animais , Sequência de Bases , Bovinos , Criptosporidiose/complicações , Criptosporidiose/epidemiologia , Criptosporidiose/parasitologia , Diarreia/etiologia , Fezes/parasitologia , Japão/epidemiologia , Dados de Sequência Molecular , Reação em Cadeia da Polimerase/veterinária , Análise de Sequência de DNA/veterinária , Especificidade da Espécie
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...